- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Canadian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
2
0 new
High return on equity, past performance and sound balance sheet.
2 companies
BioSyent
Market Cap: CA$133.1m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$11.82
7D
-0.08%
1Y
10.7%
Auxly Cannabis Group
Market Cap: CA$188.8m
Operates as a consumer packaged goods company in the cannabis products market in Canada.
XLY
CA$0.14
7D
-6.7%
1Y
250.0%